Clinical TrialSingle-armKetamineCompleted

IV Ketamine for Adolescents with Treatment-Resistant Depression: Open-Label Pilot (Cullen 2018, University of Minnesota)

Single-arm open-label Phase 2 pilot listed on ClinicalTrials.gov (NCT02078817). Participants: adolescents aged 12-18 with MDD and TRD. Intervention: six IV ketamine infusions at 0.5 mg/kg over 40 minutes over 2 weeks. The published paper defines percent change in CDRS-R from baseline to 1 day after the final infusion as the primary outcome; CTG lists CGI responder count at 2 weeks as the registered primary outcome.

Target Enrollment
13 participants
Study Type
interventional
Design
Non-randomized

Study Arms & Interventions

Ketamine

experimental

Six serial infusions of intravenous ketamine administered over 2 weeks.

Interventions

  • Ketamine0.5 mg/kg
    via IVsix infusions over 2 weeks6 doses total

    Initial dosing for first 5 participants was based on ideal body weight, then switched to actual body weight for subsequent participants.

Study Details

  • Status
    Completed
  • Type
    interventional
  • Design
    Non-randomized
  • Target Enrollment13 participants
  • Timeline
    Start: 2016-01-01
    End: 2018-01-01
  • Compound

Related Publications